Comparison between four therapeutic methods in the treatment of long head of biceps tendinitis

Comparison between therapeutic responses to ultrasound, low level LASER+ultrasound, sonographically guided extra and intra tendon's sheath corticosteroid injection in the treatment of long head of biceps tendinitis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201502257274N11

Enrollment

144

Registered

2015-03-09

Start date

2014-05-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Long head of biceps tendinitis. Bicipital tendinitis

Interventions

Intervention 1: First group-control (Ultrasound): 10 session (3 session a week) of ultrasound (frequency:1MHz, intensity:1W/cm2, Cycle: 2:8, Transducer section area: 5 cm2) for 5 minutes will administ

Rehabilitation

Treatment - Drugs

First group-control (Ultrasound): 10 session (3 session a week) of ultrasound (frequency:1MHz, intensity:1W/cm2, Cycle: 2:8, Transducer section area: 5 cm2) for 5 minutes will administer in this group

Second group-intervention (Ultrasound+Low level LASER): In addition to ultrasound like the first group, the Ga-As-Al LASER (Wave Lenght:830 nm, Power:30mW, Intensity:1 J/cm2, Beam diameter:4mm, Angle:

Fourth group-intervention (Extra tendon sheath injection): All devices and methods are similar to the third group but the injection will be executed outside the tendon sheath.

Third group-intervention (Intra tendon sheath injection): 1 ml of Methylprednisolon acetate (40 mg/ml) with 1ml of Lidocaine 2% will be injected into the long head of biceps tendon sheath using a 1.5

Eligibility

Sex/Gender

All

Age

14 Years to 139 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Presence of pain in shoulder or upper extremity for more than 3 months; Point tenderness in bicipital groove; At least one positive biceps tendon test (active compression test, Yergoson test, speed test or biceps instability); No evidence of partial or complete rotator cuff tear. Exclusion criteria: History of shoulder surgery or injection; Any calcification (or calcareous deposit) in rotator cuff; Any sign of dislocation, subluxation, partial or complete tear of long head of biceps tendon; Frozen shoulder; Diabetes mellitus.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain intensity. Timepoint: VAS score of pain which will be assessed pre-treatment, 1 week, 1 month, 3 months and one year after intervention. Method of measurement: Visual Analogue Scale score (VAS).	—

Secondary

Measure	Time frame
Functional status of shoulder. Timepoint: pre-treatment, 1 week, 1 month, 3 months and one year after intervention. Method of measurement: Constant-Morley score.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohsen Mardani Kivi MD.

Guilan University of Medical Science

dr_mohsen_mardani@yahoo.com+98 13 3331 1470

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026